Literature DB >> 34177299

Percutaneous Muscular Ventricular Septal Defect Closure with 2D Transthoracic Echocardiography: Can We Sufficiently Visualize It?

Deniz Mutlu1, Konstantinos Marmagkiolis2,3, Cezar A Iliescu1,2,3,4,5,6, Ismail Ates4,5, Mehmet Cilingiroglu4,6.   

Abstract

Ventricular septal defect (VSD) is one of the most common congenital heart diseases worldwide today. Although the majority close spontaneously, transcatheter VSD closure is a common option for symptomatic patients with suitable anatomy in adult age. Although transesophageal echocardiography (TEE) and intracardiac echocardiography are the most common imaging modalities for the procedure, in patients with poor TEE images, Transthoracic echocardiography (TTE) can be used as a reliable alternative. Here we present an adult patient with pulmonary hypertension associated with a muscular VSD which was closed percutaneously using 2-dimensional TTE because of poor TEE images. ©Copyright 2021 by the Atatürk University School of Medicine - Available online at www.eurasianjmed.com.

Entities:  

Keywords:  Congenital heart defect; Endovascular technique; Transthoracic Echocardiography; Ventricular septal defect

Year:  2021        PMID: 34177299      PMCID: PMC8184039          DOI: 10.5152/eurasianjmed.2021.20131

Source DB:  PubMed          Journal:  Eurasian J Med        ISSN: 1308-8734


  8 in total

1.  2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Karen K Stout; Curt J Daniels; Jamil A Aboulhosn; Biykem Bozkurt; Craig S Broberg; Jack M Colman; Stephen R Crumb; Joseph A Dearani; Stephanie Fuller; Michelle Gurvitz; Paul Khairy; Michael J Landzberg; Arwa Saidi; Anne Marie Valente; George F Van Hare
Journal:  J Am Coll Cardiol       Date:  2018-08-16       Impact factor: 24.094

Review 2.  Ventricular septal defect.

Authors:  Daniel J Penny; G Wesley Vick
Journal:  Lancet       Date:  2011-02-23       Impact factor: 79.321

3.  The challenge of congenital heart disease worldwide: epidemiologic and demographic facts.

Authors:  Pierre-Luc Bernier; Ada Stefanescu; Gordan Samoukovic; Christo I Tchervenkov
Journal:  Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu       Date:  2010

4.  Transcatheter closure of perimembranous ventricular septal defects: early and long-term results.

Authors:  Gianfranco Butera; Mario Carminati; Massimo Chessa; Luciane Piazza; Angelo Micheletti; Diana Gabriella Negura; Raul Abella; Alessandro Giamberti; Alessandro Frigiola
Journal:  J Am Coll Cardiol       Date:  2007-09-04       Impact factor: 24.094

5.  Transcatheter closure of ventricular septal defects.

Authors:  J E Lock; P C Block; R G McKay; D S Baim; J F Keane
Journal:  Circulation       Date:  1988-08       Impact factor: 29.690

6.  Use of Lifetech™ Konar-MF, a device for both perimembranous and muscular ventricular septal defects: A multicentre study.

Authors:  Ibrahim Cansaran Tanidir; Osman Baspinar; Murat Saygi; Mehmet Kervancioglu; Alper Guzeltas; Ender Odemis
Journal:  Int J Cardiol       Date:  2020-02-22       Impact factor: 4.164

Review 7.  Ventricular septal defect.

Authors:  Diane E Spicer; Hao H Hsu; Jennifer Co-Vu; Robert H Anderson; F Jay Fricker
Journal:  Orphanet J Rare Dis       Date:  2014-12-19       Impact factor: 4.123

8.  Minimally invasive perventricular device closure of ventricular septal defect in infants under transthoracic echocardiograhic guidance: feasibility and comparison with transesophageal echocardiography.

Authors:  Gui-Can Zhang; Qiang Chen; Hua Cao; Liang-Wan Chen; Li-ping Yang; Dao-zhong Chen
Journal:  Cardiovasc Ultrasound       Date:  2013-03-11       Impact factor: 2.062

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.